|ER stress triggers apoptosis by activating BH3-only protein Bim|
H Puthalakath, LA O'Reilly, P Gunn, L Lee, PN Kelly, ND Huntington, ...
Cell 129 (7), 1337-1349, 2007
|Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity|
PD Hughes, GT Belz, KA Fortner, RC Budd, A Strasser, P Bouillet
Immunity 28 (2), 197-205, 2008
|The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteins|
D Mérino, M Giam, PD Hughes, OM Siggs, K Heger, LA O'Reilly, ...
J Cell Biol 186 (3), 355-362, 2009
|Thrombotic microangiopathy and associated renal disorders|
T Barbour, S Johnson, S Cohney, P Hughes
Nephrology Dialysis Transplantation 27 (7), 2673-2685, 2012
|Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases|
P Hughes, P Bouillet, A Strasser
Apoptosis and Its Relevance to Autoimmunity 9, 74-94, 2006
|Kidney stones epidemiology|
Nephrology 12 (1), S26, 2007
|ABO-incompatible matching significantly enhances transplant rates in kidney paired donation|
P Ferrari, PD Hughes, SJ Cohney, C Woodroffe, S Fidler, L D’Orsogna
Transplantation 96 (9), 821-826, 2013
|ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone|
R Masterson, P Hughes, RG Walker, C Hogan, M Haeusler, ...
American journal of transplantation 14 (12), 2807-2813, 2014
|Novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial|
L Rostaing, S Bunnapradist, JM Grinyó, K Ciechanowski, JE Denny, ...
American Journal of Kidney Diseases 67 (4), 648-659, 2016
|Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease|
PDV HUGHES, GJ Becker
Nephrology 8 (4), 163-170, 2003
|Adoptive T Cell Immunotherapy for Treatment of Ganciclovir‐Resistant Cytomegalovirus Disease in a Renal Transplant Recipient|
N Macesic, D Langsford, K Nicholls, P Hughes, DJ Gottlieb, L Clancy, ...
American Journal of Transplantation 15 (3), 827-832, 2015
|Modifiers of complement activation for prevention of antibody-mediated injury to allografts|
PD Hughes, SJ Cohney
Current opinion in organ transplantation 16 (4), 425-433, 2011
|Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the A ustralian compassionate access cohort|
A Mallett, P Hughes, J Szer, A Tuckfield, C Van Eps, SB Cambell, ...
Internal medicine journal 45 (10), 1054-1065, 2015
|Life-threatening rhabdomyolysis following the interaction of two commonly prescribed medications.|
HP Fallah A, Deep M, Smallwood D
Australas Med J 6 (3), 112–114, 2013
|Retinal disease in the C3 glomerulopathies and the risk of impaired vision|
J Savige, L Amos, F Ierino, HG Mack, RCA Symons, P Hughes, K Nicholls, ...
Ophthalmic genetics 37 (4), 369-376, 2016
|Antiphospholipid syndrome in renal transplantation|
TD Barbour, A Crosthwaite, K Chow, MJ Finlay, N Better, PD Hughes, ...
Nephrology 19 (4), 177-185, 2014
|Waiting time between failure of first graft and second kidney transplant and graft and patient survival|
G Wong, S Chua, SJ Chadban, P Clayton, H Pilmore, PD Hughes, ...
Transplantation 100 (8), 1767-1775, 2016
|Impact of loss of NF‐κB1, NF‐κB2 or c‐REL on SLE‐like autoimmune disease and lymphadenopathy in Faslpr/lpr mutant mice|
JT Low, P Hughes, A Lin, U Siebenlist, R Jain, K Yaprianto, DHD Gray, ...
Immunology and cell biology 94 (1), 66-78, 2016
|C5 Inhibition with Eculizumab To Prevent Antibody Mediated Rejection (AbMR) in Patients with Donor Specific Anti-HLA Antibody (DSAb) and a Positive Cross Match.: Abstract# 1557 …|
S Cohney, P Hughes, M Rosemary, R Walker, L Cantwell, ...
American Journal of Transplantation 11, 2011
|Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms|
P Hughes, M Robati, W Lu, J Zhou, A Strasser, P Bouillet
Cell death and differentiation 13 (7), 1123, 2006